PAPER Amorim MA, Guerra-Araiza C, Pernía O, da Cruz E Silva EF, Garcia-Segura LM

Progesterone regulates the phosphorylation of protein phosphatases in the brain.

J Neurosci Res. 2010 Oct;88(13):2826-32. PubMed: 20568292

PAPER Wittwer M, Grandgirard D, Rohrbach J, Leib SL

Tracking the transcriptional host response from the acute to the regenerative phase of experimental pneumococcal meningitis.

BMC Infect Dis. 2010;10:176. PubMed: 20565785

PAPER Capsoni S, Tiveron C, Vignone D, Amato G, Cattaneo A

Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration.

Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12299-304. PubMed: 20566851

PAPER

Trial watch: NeuroSearch's dopaminergic stabilizer improves movement disorders in Huntington's disease.

J Clin Exp Neuropsychol. 2010 Oct;32(8):793-808. PubMed: 20357796

PAPER Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.

Brain. 2010 Jun;133(Pt 6):1747-54. PubMed: 20413575

PAPER Gonsette RE

Endogenous neuroprotection in multiple sclerosis.

Acta Neurol Belg. 2010 Mar;110(1):26-35. PubMed: 20514924

PAPER Sahores M, Gibb A, Salinas PC

Frizzled-5, a receptor for the synaptic organizer Wnt7a, regulates activity-mediated synaptogenesis.

Development. 2010 Jul;137(13):2215-25. PubMed: 20530549

PAPER Amante DJ, Kim J, Carreiro ST, Cooper AC, Jones SW, Li T, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Ferrante RJ, Rusche J

Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice.

Amyotroph Lateral Scler. 2010 Dec;11(6):520-30. PubMed: 20565334

PAPER Hawkins BJ, Levin MD, Doonan PJ, Petrenko NB, Davis CW, Patel VV, Madesh M

Mitochondrial complex II prevents hypoxic but not calcium- and proapoptotic Bcl-2 protein-induced mitochondrial membrane potential loss.

J Biol Chem. 2010 Aug 20;285(34):26494-505. PubMed: 20566649

AβPP

ANTIBODY polyclonal manufacturer Cat# LS-C68961<br /> manufacturer: LifeSpan Biosciences immunogen = synthetic peptide corresp. to aa1-40 of β-amyloid conjugated to KLH liquid, PBS, BSA, azide, affinity purified specific to human β-amyloid 1-40; weak cross-r

AβPP

ANTIBODY polyclonal manufacturer Cat# LS-C68958<br /> manufacturer: LifeSpan Biosciences immunogen = synthetic peptide corresp. to aa1-17 of β-amyloid conjugated to KLH liquid, PBS, BSA, azide, affinity purified specific to human β-amyloid 1-40 and β-amyloid

AβPP

ANTIBODY polyclonal manufacturer Cat# LS-C3642<br /> manufacturer: LifeSpan Biosciences immunogen = synthetic peptide corresp. to N-terminal of human APP liquid, PBS, BSA, azide, affinity purified recognizes APP (β-APP770), mwt 110kD; predicted to recognize

AβPP

ANTIBODY polyclonal manufacturer Cat# LS-C20572<br />manufacturer: LifeSpan Biosciences immunogen = synthetic peptide corresp. to aa12-28 (NH2-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH) near the C-terminal of β-amyloid peptide (B

AβPP phos Thr668

ANTIBODY polyclonal manufacturer Cat# LS-C48067<br />manufacturer: LifeSpan Biosciences immunogen = peptide corresp. to human amyloid A4 protein precursor (APP) or 85-99 of the C99 fragment generated by β-secretase cleavage liquid, PBS, azide AβPP expect bov

AβPP

ANTIBODY polyclonal manufacturer Cat# LS-C313<br /> manufacturer: LifeSpan Biosciences immunogen = synthetic peptide corresp. to aa 737-751 of human amyloid A4 protein precursor (APP) or 85-99 of the C99 fragment generated by β-secretase cleavage liquid, PBS